Eczema (Age 2-5)
Atopic Dermatitis (Eczema)
This study is for participants ages 2-5 with Atopic Dermatitis (AD), also called Eczema.
The study investigates a topical cream, applied once daily, to reduce inflammation and improve symptoms associated with AD. 2 in 3 participants (67%) will receive the actual drug, and 1 in 3 participants (33%) will receive a placebo.
Study participants will receive compensation for their participation.
This study is open at our Southshore locations,
Call us at:
You may also fill out the contact form below: